Biotechnology & Biosecurity

International Forum of Biodiversity, Biomedicine, Biotechnology, Biosecurity (4Bio)




Meeting Center of Wenzhou Medical University,


Wenzhou, Zhejiang




In October 2019, the first World Young Scientist Summit was successfully held in Wenzhou. More than 800 guests from 85 countries around the world, including Nobel Prize winners, overseas academicians, representatives of young scientists and leaders of international science and technology organizations, attended the summit to talk about scientific and technological innovation and the social responsibility of young scientists.

In his 2020 New Year address, UN Secretary General Antonio Guterres said: “Youth is the hope of the world today. The world needs a younger generation. You should speak up, keep your ideals, break the confines, and move forward, I am encouraged by your passion and determination. You seek to play the right role in shaping the future. I support you, the United Nations supports you, and belongs to you.”

At present, the global spread of the COVID-19 epidemic has brought great challenges to the world. Great changes are taking place in the world public health system, the international order, and social dynamics. Youth, as the future of the world, needs to share ideas and unite for the building of a community with shared future for the mankind and creating a better future for human development. In order to better implement the UN SDGs by 2030, build a better platform for international cooperation in innovation and technology, and serve local scientific and technological development and industrial innovation, the International Forum of Biodiversity, Biomedicine, Biotechnology, and Biosecurity (4Bio) is initiated within the framework of the "World Young Scientist Summit 2020".

The objective of this session is to bring together global leaders in life sciences to understand new ways to overcome the barriers and threats to biological harmony on our planet that benefits all of the humanity. Our panel consists of a diverse range of researchers, entrepreneurs and policymakers that will discuss how to protect biodiversity, avoid threats and maximize positive effects from it through conducting international collaborative projects that can identify new compounds for treating human disease and sustain local communities. There will be case study presentations on the value of neglected species with life-saving bioactive properties, as well as review of political and economic tools to harness biological resources for the future of the planet.


Morning of 11 September 11 2020, arrival and check-in.
Afternoon of 11 September 2020, opening ceremony+official meeting.

Proposed Agenda

Opening Ceremony

Time: 14:00 -15:00 PM 11st September, 2020 (Beijing time, GMT+8)
Prof. Shengwei JIN, Deputy President, Wenzhou Medical University (China)
Remark address:
Prof. Xiaokun li, President of Wenzhou Medicine University
Dr. Alexander Kagansky, FEFU, MIPT, Bio2Bio@GYA, A global strategy of Bio2Bio
Prof. Anindita Bhadra, Co-Chair of Global Young Academy, Biodiversity is Vital to Heal the Earth
Keynote Speakers:
Prof. Alexander Gabibov, Director of IBCh, Russia and Member of Russian Academy of Sciences
Prof. Stefano Govoni, Deputy President , Pavia Univeristy, Italy
Dr. Anton Gopka, Dean at itmotech, ITMO University, Russia
Prof. Theodore Hupp, Director of ICCVS, Poland and Chair of Cancer Research, Edinburgh University, UK
Dr. Yi SHI, Chair of Youth Innovation Promoting Association, CAS, China, Presentation title: Emerging viruses and human health

Biodiversity and biosecurity problems and ways to tackle them

Time: 15:10 -16:30 PM 11.09 2020 (Beijing time, GMT+8)
At the onset of the Decade of Action to achieve the United Nations Sustainable Development Goals (SDGs), COVID-19 has disrupted the world. Climate change, biodiversity loss, fragile health systems, dwindling economies, and social disintegration could be exacerbated by the response to the pandemic. In this special session, we hope to jointly explore cooperation in Biodiversity and biosecurity and other fields through dialogue between Europe and Asia. The topics are set as follows:
○ Pandemics as a response of the disrupted ecosystem;
○ International, regional and national policies for biodiversity protection;
○ Development of the unified biodiversity surveillance mechanisms;
○ Biosecurity, open science, and common responsibility of global researchers;
○ Development and utilization of underground space in ancient building area;
○ Do-It-Yourself Biology and Genetic modification: risks and opportunities;
○ What a new Bio2bio center can do?
Prof. Xu Wang, Wenzhou Medical University, China
Prof. Milica Pesic, University of Belgrade, Serbia
Velia Siciliano (Italy) Bio2bio and DIY bio
Ross Piper (UK) Drugs from the Bugs
Uttam Shresha (Nepal) Fungi to save us
Dr. Vidushi Neergheen (Mauritius), Opportunities and Challenges from a Small Island Developing State
Dr. Baojun SUN, Latitudinal pattern of reptile responses to climate warming and underlying mechanisms
Dr. Shuhui SONG, The global landscape of SARS-CoV-2 genomes, variants, and haplotypes in 2019nCoVR
Vadim Kumeiko (Russia), Marine biodiversity for medicine
Dilfuza Egamberdieva (Uzbekistan), Endophytes of herbal plants: unexplored treasure of natur.
Roman Korchigin (Russia), Wildlife reserves of Russia
Dr. Shuran Li, Wenzhou University, China, Young delegation of International Society of Zoological Sciences, ISZS
Dr. Shuhui SONG, Biosecurity expert (China)

Biotechnology and Biomedicine

Time: 16:45-18:30 PM 11st September, 2020 (Beijing time, GMT+8)
To create new paradigms for conservation based on the ecosystem service of drug discovery, partnerships are needed among scientists to identify species and isolate compounds, social scientists to assess community needs and ensure community empowerment, and policy makers to produce legislation to guide protection and to develop models for sustainable agriculture and research involving modern biotechnology and chemistry. Here we need to create a common platform for:
○ collecting, cataloguing, and curating the traditional knowledge;
○ collecting evidences from existing peer reviewed academic literature;
○ make recommendations for new drug discovery based on acquired information from the traditional knowledge and existing research;
○ creating a comprehensive searchable database of the collected traditional medicine information with links to existing research publications;
○ examining and curating existing national and international policies and intellectual property laws regarding discovery and use of medicinal compounds/species in different countries; conservation policies and laws for using the natural products;
○ establishing the connection with traditional/natural medicine industry for potential collaboration with research (e.g. to develop a new research funding scheme);
○ understanding the traditional medicines and pseudomedicines “market” in various geographic areas (geography, species) and its’ impact on habitats, species, and humans.
○ exploration of the new and existing sustainable gateways of natural medicines into the pharma, food and cosmetics.
Prof, Shaobo FANG, Institute of Physics, Chinese Academy of Sciences
Prof. Dilfuza Egamberdieva (Uzbekistan)
Neil Carragher (UK) Edinburgh Drug Discovery via phenotypic screening
Andrey Konevega (Russia) Novel antibiotics from nature
Milica Pesic (Serbia), Synthetic Biology for the future of healthcare
Carla Montesano (Italy), Xenogenic miRNA for Healthcare
Dr. Jianzhong SU, Wenzhou Medical University (China), Pathway Analysis of Single-cell Transcriptomes Tracing Cancerous Origin
Prof, Shaobo FANG, Institute of Physics, Chinese Academy of Sciences, Multimodal multiphoton microscopy for bioimaging
Dr. Tao HUANG, Shanghai Institute of Nutrition and Health, Chinese Academy of Sciences, Accelerate Precision Medicine with Machine Learning and Network Analysis of Biomedical Big Data
Prof. Fangfu YE, China Academy of Sciences, Microenvironment's regulation of cell's physical behaviors
Florencia Tevy (Argentina) Genome engineering
Wahaj Uddin (India), Pharmacokinetics
Andrey Pangaev (Russia) Medicinal herbs for health
Prof. Tao HUANG, CAS, Biomedicine expert (China)
Other CEOs in Medicine industry

Closed Door Meeting for Bio2Bio Committee

Time: 20:00 - 20:30, 11.09, 2020 (Beijing time, GMT+8)
Dr. Alexander Kagansky, Far East Federation University, MIPT, Bio2Bio
Dr. Meng WANG, World Young Scientist Summit
This is meeting for the committee of Bio2Bio to discuss on the plan and future work on this initiative, and to review all proposals for the members.

Registration & Contact

Meeting website:

For registration, please log in and enter “Dialogue with the Future”, then the special topic of "4Bio" section.
Meeting registration:

Invitation of experts, agenda of the meeting:

Contact: Dr. Alexander Kagansky E-mail:
Contact: Dr. Meng WANG Tel: +86-13426054010 E-mail:

Meeting services and accommodation:
Contact: Mr. Zhifeng HUANG
Contact: Mr. Lu Hui Tel: +86-13776573457 E-mail:



Alexander Kagansky